Stone Capital Group partners with LumiraDx to offer comprehensive COVID-19 testing solutions for mass screening settings
Your Content Goes Here Results are encouraging May 24th, 2021: Stone Capital Group, a company comprised of high-complexity clinical reference laboratories, distribution, and mobile laboratory business unit (#Stone Direct Diagnostics) announced today that the Company has entered a strategic Services and Co-Marketing partnership with LumiraDx, a next-generation point of care (POC) diagnostics [...]